0001062993-22-002726.txt : 20220204
0001062993-22-002726.hdr.sgml : 20220204
20220204192638
ACCESSION NUMBER: 0001062993-22-002726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zarur Juan Andrey
CENTRAL INDEX KEY: 0001727404
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39894
FILM NUMBER: 22595166
MAIL ADDRESS:
STREET 1: C/O SOLID BIOSCIENCES, LLC
STREET 2: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GreenLight Biosciences Holdings, PBC
CENTRAL INDEX KEY: 0001822691
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851914700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BOSTON AVENUE
STREET 2: SUITE 3100
CITY: MEDFORD
STATE: MA
ZIP: 02155
BUSINESS PHONE: (617) 616-8188
MAIL ADDRESS:
STREET 1: 200 BOSTON AVENUE
STREET 2: SUITE 3100
CITY: MEDFORD
STATE: MA
ZIP: 02155
FORMER COMPANY:
FORMER CONFORMED NAME: Environmental Impact Acquisition Corp
DATE OF NAME CHANGE: 20200826
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-02-02
0001822691
GreenLight Biosciences Holdings, PBC
GRNA
0001727404
Zarur Juan Andrey
C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC
200 BOSTON AVENUE, SUITE 3100
MEDFORD
MA
02155
1
1
0
0
President & CEO
Common Stock
2022-02-02
4
A
0
896058
A
896058
D
Stock Option (Right to Buy)
0.35
2022-02-02
4
A
0
70319
A
2023-07-29
Common Stock
70319
70319
D
Stock Option (Right to Buy)
0.33
2022-02-02
4
A
0
926330
A
2028-09-13
Common Stock
926330
926330
D
Stock Option (Right to Buy)
0.50
2022-02-02
4
A
0
1982609
A
2029-12-29
Common Stock
1982609
1982609
D
Stock Option (Right to Buy)
0.50
2022-02-02
4
A
0
668830
A
2029-12-29
Common Stock
668830
668830
D
Stock Option (Right to Buy)
0.98
2022-02-02
4
A
0
1906944
A
2030-12-01
Common Stock
1906944
1906944
D
Stock Option (Right to Buy)
0.98
2022-02-02
4
A
0
292649
A
2030-12-01
Common Stock
292649
292649
D
Issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for capital stock previously issued by such company.
100% of the shares subject to this option are fully vested and exercisable.
This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
20% of the shares underlying the option vested or shall vest on September 12, 2018 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting October 12, 2018.
20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting December 5, 2021.
20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting December 5, 2021.
25% of the shares underlying the option vested or shall vest on December 1, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 1, 2022.
25% of the shares underlying the option vested or shall vest after one year of service and the remainder of the shares vested or shall vest in 36 equal monthly installments.
/s/ David Kennedy, Attorney-in-fact
2022-02-04